Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Potential new treatments for type 2 diabetes
Clifford J. Bailey
*
*
Corresponding author for this work
School of Biosciences
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Cell & Tissue Biomedical Research
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Potential new treatments for type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glycemic Control
50%
Insulin Resistance
50%
Cardiovascular Disease
50%
Metabolic
50%
Insulin Secretion
50%
Antidiabetic Agents
50%
Natural History
50%
Suboptimal Glycemic Control
50%
Retinopathy
50%
Microvascular Disease
50%
Therapeutic Challenges
50%
Serious Complications
50%
Morbidity Mortality
50%
Impaired Insulin Secretion
50%
New Antidiabetic Drugs
50%
Endocrine Disorders
50%
Nephropathy
50%
Premature Mortality
50%
Intensive Use
50%
Long-term Complications
50%
Type 2 Diabetes Mellitus Patients
50%
Year of Diagnosis
50%
Chronic Hyperglycemia
50%
Morbidity Burden
50%
Control Delay
50%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Antidiabetic Agent
66%
Glycemic Control
66%
Insulin Release
33%
Insulin Resistance
33%
Hyperglycemia
33%
Cardiovascular Disease
33%
Retinopathy
33%
Nephropathy
33%
Premature Mortality
33%
Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Antidiabetic Agent
66%
Insulin Resistance
33%
Hyperglycemia
33%
Cardiovascular Disease
33%
Retinopathy
33%
Kidney Disease
33%
Premature Mortality
33%
Biochemistry, Genetics and Molecular Biology
Glycemic Control
100%
Hyperglycemia
50%
Insulin Release
50%
Insulin Resistance
50%
Premature Mortality
50%
Immunology and Microbiology
Glycemic Control
100%
Insulin Resistance
50%
Insulin Release
50%
Premature Mortality
50%
Insulin
50%